08 g/mL in iodixanol gradient (corresponding to 1.18 g/mL in sucrose gradient) and were infectious as indicated by passage to naïve HepaRG cells; (3) HCV E1E2 and core protein accumulation in the cytoplasm of infected cells 1 month p.i.; (4) complete reduction of HCV RNA and infectious virus in HepaRG culture supernatants (97% at 3 weeks

Adriamycin supplier p.i.) by E1E2-specific mAb D32.107-9 at low concentration (0.5 μg/mL) even when the infection was performed in the presence of NHS; (5) ability of infected-HepaRG cells to produce high titers of HCV RNA (4 to 5log10) as complete virus particles in culture media after freezing/thawing and subculture(s) followed by induction of the differentiation process; (6) production of apoE/apoB-associated HCV virions by the HepaRG cells similar to authentic patient-derived HCV particles11, 14; (7) observation of typical positive-strand RNA click here virus-induced membrane rearrangements18 and detection of HCV E1E2 antigen in association with vesicular structures in ER and at a submembranous localization in HCVsp-RG cells. Very recently, a cell-culture-based system was established using PHHs inoculated with HCVcc.16 Even if freshly isolated PHHs are currently the in vitro “gold standard” of human liver

cells, the HepaRG human hepatic cell line is now increasingly used as a surrogate for PHHs in pharmaceutical research and development for metabolism studies.17

Here, our results cAMP demonstrate that HepaRG cells can be infected with serum-derived HCV of genotype 3 and persistently produce infectious enveloped HCV particles with biophysical and immunological properties similar to circulating7, 11 and infected liver-derived10 HCV. The major contributions of our study were to use a genuine HCV isolate from patients distinct from the JFH-1 or Jc1 virus of genotype 2a together with the HepaRG cell line, which possesses key features of authentic hepatocytes. Of course, the current Huh-7-derived HCVcc system remains the “gold standard,” and it would have been optimal to successfully infect HepaRG cells with HCVcc. Unfortunately, only a weak transient replication was obtained in our laboratory when we tried to inoculate differentiated HepaRG cells with a highly infectious JFH-1 inoculum (Durantel et al., unpubl. data). This could be due to the production of type-I interferons in the culture medium,18 which likely should inhibit HCV replication and spreading. This could also explain why the HepaRG cells are only susceptible to HCVsp infection when they exhibit dedifferentiated, depolarized epithelial phenotype associated with an immature innate immunity, resistance to apoptosis, and cellular growth.